Beech Hill Advisors’s GSK GSK Stock Holding History

Beech Hill Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,360	Closed	-$397K	–	86
2016 Q3	$397K	Buy	+7,360	New	+$404K	0.24%	57

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Beech Hill Advisors's GSK Position: Q4 2016 in Review

Beech Hill Advisors sold out of GSK (GSK) in Q4 2016, closing a stake of 7,360 shares — an estimated $397K sold.

Beech Hill Advisors first reported a position in GSK in Q3 2016 and held it in 1 quarter. The position peaked at $397K in Q3 2016. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

Beech Hill Advisors reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
Beech Hill Advisors sold 7,360 GSK shares in Q4 2016, an estimated $397K.
Beech Hill Advisors first reported a position in GSK in Q3 2016 and held it in 1 quarter.
Beech Hill Advisors's GSK position peaked at $397K in Q3 2016.
762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Beech Hill Advisors's 13F filing for Q4 2016, filed 26 Jan 2017.